To request a free sample copy of this report, please complete the form below.
What people say about us!

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

logos logos logos logos logos
Analyst Support
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.



Vertigo Treatment Market size was valued at USD 1.36 billion in 2022 and is poised to grow from USD 1.42 billion in 2023 to USD 2 billion by 2031, growing at a CAGR of 4.4% in the forecast period (2024-2031).

The vertigo treatment market is still quite fragmented and far from consolidation, which makes it a highly competitive market in all parts of the world. vertigo treatment providers are investing heavily in the research and development of new medications and therapies to maximise their growth potential and revenue generation. Collaborations, mergers, partnerships, and acquisitions are also predicted to be key strategies that vertigo treatment companies will opt for to maximise their business reach in different parts of the world. vertigo treatment providers can also take advantage of new awareness initiatives launched by non-profit public health organisations and governments around the world. Companies are also focusing on launching new medications and drugs to cater to the growing demand for vertigo treatment on a level. 'AdvaCare Pharma', 'GlaxoSmithKline', 'WellSpring Pharmaceutical Corporation', 'Mylan N.V.', 'Amneal Pharmaceuticals LLC', 'Lupin', 'Auris Medical', 'Prestige Consumer Healthcare Inc.', 'Vintage Labs', 'Casper Pharma', 'Epic Pharma, LLC', 'Sagent Pharmaceuticals', 'Pfizer Inc.', 'ANI Pharmaceuticals', 'Teva Pharmaceutical Industries Ltd.'

The number of ageing people around the world is rising rapidly and it has been found that the probability of experiencing vertigo increases with age, hence, expanding geriatric population is a key factor driving vertigo treatment demand.

Novel Diagnostic and Drug Delivery Methods: Advancements in diagnostic technologies will allow companies to come up with better diagnostic techniques and boost their revenue generation as well. Vertigo treatment providers are also estimated to opt for novel drug delivery methods to deliver the medication to specific parts of the body and reduce the side effects of different drugs.

North America accounts for a dominant share of the vertigo treatment market. The surging prevalence of vertigo in the aging population of this region is the prime factor driving vertigo treatment demand. The presence of key pharmaceutical companies in this region has also contributed to the high availability of different vertigo drugs and treatments. The United States and Canada are forecasted to emerge as the leading markets in this region for vertigo treatment providers in the future. Women in this region are more susceptible to suffering from vertigo as compared to men. Growing investments in medical research and government support for the same are also estimated to foster innovation in the vertigo treatment market and boost market growth going forward.

Feedback From Our Clients

Global Vertigo Treatment Market

Product ID: SQMIG35I2311